This section of the website is for UK Healthcare Professionals only. 
If you are not a Healthcare Professional, please click here.

Optimising PBC Care: On-Demand Webinar 1 – March 2025

Primary Biliary Cholangitis (PBC) Video
52:21

Gain practical insights into the evolving management of Primary Biliary Cholangitis (PBC) in this engaging, expert-led session. Explore the PBC landscape, shifting treatment patterns, review key clinical trial data, and delve into a real-world case study highlighting the challenges and considerations in PBC care.

This webinar is ideal for healthcare professionals looking to stay up-to-date with the latest thinking in PBC care and improve outcomes for their patients.

Featuring:
Dr. Kuldeep Cheent, Consultant Gastroenterologist and Hepatologist, Frimley Health NHS Foundation Trust
Dr. Yiannis Kallis, Consultant Hepatologist, Barts Health NHS Trust; Honorary Consultant Transplant Hepatologist, Royal Free London

The session concludes with a recorded live Q&A featuring both expert speakers.

IQV-UK-000304 | April 2025

Explore more Primary Biliary Cholangitis (PBC) Events & Meetings

Explore more Primary Biliary Cholangitis (PBC) Events & Meetings

Browse

To access relevant information about Primary Biliary Cholangitis, please confirm the following:

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.